S

Seoulin Bioscience Co Ltd
KOSDAQ:038070

Watchlist Manager
Seoulin Bioscience Co Ltd
KOSDAQ:038070
Watchlist
Price: 6 300 KRW -3.52% Market Closed
Market Cap: 57.3B KRW

Operating Margin

0.5%
Current
Declining
by 2.4%
vs 3-y average of 2.9%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
0.5%
=
Operating Income
₩397m
/
Revenue
₩76.7B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
0.5%
=
Operating Income
₩397m
/
Revenue
₩76.7B

Peer Comparison

Country Company Market Cap Operating
Margin
KR
Seoulin Bioscience Co Ltd
KOSDAQ:038070
55.6B KRW
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
378.8B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
177.8B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
155.1B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
112.1B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.2B USD
Loading...
AU
CSL Ltd
ASX:CSL
85.7B AUD
Loading...
NL
argenx SE
XBRU:ARGX
41.2B EUR
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.3B USD
Loading...
No Stocks Found

Market Distribution

In line with most companies in Korea
Percentile
38th
Based on 2 615 companies
38th percentile
0.5%
Low
-163 055.6% — -2.2%
Typical Range
-2.2% — 6.8%
High
6.8% — 22 874.8%
Distribution Statistics
Korea
Min -163 055.6%
30th Percentile -2.2%
Median 2.7%
70th Percentile 6.8%
Max 22 874.8%

Seoulin Bioscience Co Ltd
Glance View

Market Cap
57.3B KRW
Industry
Biotechnology

SeouLin Bioscience Co., Ltd. engages in the provision of lifescience total solutions. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2005-10-25. The firm mainly engages in research and development of reagents, such as deoxyribonucleic acid (DNA) chips, which are used for gene therapy, clinical diagnosis, organs transplantation and biopsy; stem cells, which are used for treatment of incurable diseases, Alzheimer disease and others, and next-generation biotechnology drugs. The firm supplies its products under the brand name MyLab. The company also imports bio research equipment from Thermo Fisher, Affymetrix, Sarstedt and others, and markets in the domestic market. In addition, the Company engages in the real estate rental business.

Seoulin Bioscience Co Ltd Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
0.5%
=
Operating Income
₩397m
/
Revenue
₩76.7B
What is Seoulin Bioscience Co Ltd's current Operating Margin?

The current Operating Margin for Seoulin Bioscience Co Ltd is 0.5%, which is below its 3-year median of 2.9%.

How has Operating Margin changed over time?

Over the last 3 years, Seoulin Bioscience Co Ltd’s Operating Margin has decreased from 8.7% to 0.5%. During this period, it reached a low of -0.3% on Jun 30, 2025 and a high of 8.9% on Dec 31, 2022.

Back to Top